{"id":89307,"date":"2021-10-11T10:14:23","date_gmt":"2021-10-11T14:14:23","guid":{"rendered":"http:\/\/stateofthenation.co\/?p=89307"},"modified":"2021-10-11T10:14:23","modified_gmt":"2021-10-11T14:14:23","slug":"100-to-200-congressional-reps-and-staff-were-successfully-treated-with-ivermectin","status":"publish","type":"post","link":"https:\/\/stateofthenation.co\/?p=89307","title":{"rendered":"100 to 200 Congressional Reps and Staff Were Successfully Treated with Ivermectin"},"content":{"rendered":"

Report, 100 to 200 Congressional Reps and Staff Were Treated with Ivermectin Protocol From Front Line COVID Critical Care Doctors<\/h1>\n

The Last Refuge<\/p>\n

This is beyond disturbing.<\/strong>\u00a0 According to Dr Pierre Kory, MD, MPA, and verified by the Front Line COVID-19 Critical Care Alliance<\/a> (FLCCC), 100 to 200 congressional reps and\/or staff and families who contracted COVID-19 were treated with the Front Line Ivermectin protocol. [LINK<\/a> and LINK<\/a>]<\/p>\n

\"\"<\/p>\n

This successful treatment is happening at the same time many congressional representatives are playing politics in favor of the vaccine; downplaying the effective anti-viral treatment and therapeutic<\/span> approach with Ivermectin; and taking action to block regular American citizens from seeking similar treatment with Ivermectin.<\/p>\n

Congress can seek treatment with a medication they simultaneously deny to others?\u00a0 This is well beyond a \u201cscandal\u201d, and needs to be investigated quickly.<\/p>\n

Additionally, as Merck has announced a new and similar anti-viral drug called Molnupiravir, two trial studies in India have requested to exit the trials.\u00a0 Apparently the issue surrounds the new drug providing no benefit once a patient is moderately ill and hospitalized (READ MORE, Reuters Link<\/a>).<\/p>\n

Dr. John Campbell highlights a comparison between Ivermectin and Molnupiravir below:<\/p>\n